News
HLTH
0.1460
-2.67%
-0.0040
Cue Health Announces CFO Transition and New Appointment
TipRanks · 19h ago
CUE HEALTH INC - ON APRIL 23 BOARD APPROVED APPOINTMENT OF RANDALL POLLARD, AS PRINCIPAL FINANCIAL OFFICER OF COMPANY
Reuters · 20h ago
Weekly Report: what happened at HLTH last week (0415-0419)?
Weekly Report · 3d ago
12 Health Care Stocks Moving In Friday's Pre-Market Session
Chromocell Therapeutics (AMEX:CHRO) stock increased by 21.6% to $1.49 during Friday's pre-market session. Kineta stock moved upwards by 16.62% and Erasca stock rose 13.73%. Nexalin Technology (NASDAQ:NXL) stock fell 18.4% during the day.
Benzinga · 5d ago
12 Health Care Stocks Moving In Monday's After-Market Session
Dynatronics (NASDAQ:DYNT) stock increased by 70.1% to $0.63 during Monday's after-market session. Cardio Diagnostics Hldgs stock rose 14.28% and Aptorum Gr shares rose 12.61%. Poseida Therapeutics ( NASDAQ:PSTX) shares declined by 15.2% during the session.
Benzinga · 04/15 20:31
Weekly Report: what happened at HLTH last week (0408-0412)?
Weekly Report · 04/15 09:02
BUZZ-U.S. STOCKS ON THE MOVE-Chemours, Lucid, OppFi
U.S. Stocks reverse early gains ahead of key inflation print. Dow Jones Industrial Average down 0.36%; S&P 500 and Nasdaq Composite also down. Chemours, Lucid, OppFi among the top stocks on the move. Lucid Group down 3.9% after announcing potential sale of parts of company.
Reuters · 04/09 18:19
BUZZ-U.S. STOCKS ON THE MOVE-Digital Realty, Alphabet, Moderna
Dow Jones Industrial Average was down 0.52% on Tuesday. Wall Street's main stock indexes gained on Tuesday supported by retreating Treasury yields. Investors await a key inflation print later in the week that could help shape the Fed's stance on interest-rate cuts. Digital Realty, Alphabet, Moderna are among the day's top stocks.
Reuters · 04/09 16:20
BUZZ-Cue Health rises after disclosing potential sale part of strategic options
Medical testing company Cue Health rises after disclosing potential sale part of strategic options. Shares of Cue Health rise 3.15% to 18 cents. FDA says company's RSV molecular test does meet criteria for over-the-counter use. Co had cash and cash equivalent of $80.9 million as of Dec. 31.
Reuters · 04/09 14:37
Cue Health Disclosed It Has Been Undertaking Comprehensive Review Of Strategic Alternative; Strategic Review Process To Evaluate Options Including Potential Sale
Benzinga · 04/09 13:08
CUE HEALTH - FDA SAYS CUE RSV MOLECULAR TEST DOES NOT MEET CRITERIA FOR CLASSIFICATION INTO CLASS I OR CLASS II FOR PROPOSED OTC INDICATIONS OF USE
Reuters · 04/09 13:02
CUE HEALTH INC - STRATEGIC REVIEW PROCESS IS INTENDED TO EVALUATE A BROAD RANGE OF OPTIONS, INCLUDING A POTENTIAL SALE OF COMPANY
Reuters · 04/09 13:02
Weekly Report: what happened at HLTH last week (0401-0405)?
Weekly Report · 04/08 09:02
Weekly Report: what happened at HLTH last week (0325-0329)?
Weekly Report · 04/01 09:02
Cue Health Finalizes Separation Terms with Ex-Officer Khattak
Cue Health Inc. Has finalized a separation agreement with Mr. Khattak, who left the company on March 19, 2024. He is eligible for severance benefits. This move could potentially influence Cue Health's market position and is a significant development for investors monitoring company leadership.
TipRanks · 03/29 20:23
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Kezar Life Sciences (KZR), Fisher & Paykel Healthcare Corporation Limited (OtherFSPKF) and Cue Health (HLTH)
TipRanks · 03/25 12:20
Weekly Report: what happened at HLTH last week (0318-0322)?
Weekly Report · 03/25 09:02
Cue Health’s Hold Rating Amidst Leadership Changes and FDA Setbacks
TipRanks · 03/22 10:17
Cue Health Names Clint Sever as CEO, Plans Review of Operations
Clint Sever, the company's co-founder and current chief product officer, is appointed as chief executive officer of Cue Health. He succeeds Ayub Khattak, who is stepping down as CEO, president and chairman. Cue Health says it will initiate a comprehensive review of its business and operations.
Dow Jones · 03/20 21:51
Cue Health Announces Major Leadership Restructuring
TipRanks · 03/20 21:42
More
Webull provides a variety of real-time HLTH stock news. You can receive the latest news about Cue Health Inc. through multiple platforms. This information may help you make smarter investment decisions.
About HLTH
Cue Health Inc. is a healthcare technology company. The Company is engaged in providing individuals with a connected diagnostic platform that bridges the physical and virtual care continuum. Its platform, Cue Integrated Care Platform, which consists of hardware, software and diagnostic components: the Cue Health Monitoring System, which is made up of a portable, durable and reusable reader, or Cue Reader, a single-use test cartridge, or Cue Cartridge, and a sample collection wand, or Cue Wand; Cue Data and Innovation Layer, with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, including its app and Cue Enterprise Dashboard, and its Cue Ecosystem Integrations and apps, which allow for integrations with third party applications and sensors. Its products include Cue Reader, COVID-19 Test, Cue Test Kits, Cue Care, and Cue+ Membership. It offers solutions for home/personal, business, public sector, healthcare, retail pharmacies, entertainment and education sectors.